Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
American Journal of Physiology. Heart and Circulatory Physiology|December 1, 2023
A modified mouse model of Friedreich's ataxia with conditional Fxn allele homozygosity delays onset of cardiomyopathyTyler L Perfitt, Claudia Huichalaf, Renea Gooch, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 22, 2021
Experiments in the EpiDerm 3D Skin In Vitro Model and Minipigs In Vivo Indicate Comparatively Lower In Vivo Skin Sensitivity of Topically Applied Aneugenic CompoundsMaik Schuler, Lindsay Tomlinson, Michael Homiski, et al.
Toxicologic Pathology|November 30, 2020
Zucker Lean Rats With Hepatic Steatosis Recapitulate Asymptomatic Metabolic Syndrome and Exhibit Greater Sensitivity to Drug-Induced Liver Injury Compared With Standard Nonclinical Sprague-Dawley Rat ModelTimothy P LaBranche, Anna K Kopec, Srinivasa R Mantena, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 4, 2010
Pharmacogenomic, physiological, and biochemical investigations on safety and efficacy biomarkers associated with the peroxisome proliferator-activated receptor-gamma activator rosiglitazone in rodents: a translational medicine investigationXinkang Wang, Xiaorong Liu, Yutian Zhan, et al.
Scientific Reports|November 9, 2017
CXCL10/CXCR3 axis is associated with disease activity and the development of mucocutaneous lesions in patients with Behçet's diseaseSang Jin Lee, Shin Eui Kang, Eun Ha Kang, et al.
Stroke|February 8, 2003
Inhibition of factor Xa reduces ischemic brain damage after thromboembolic stroke in ratsXinkang Wang, Lin Xu, Hugh Wang, et al.
Plos One|May 13, 2016
Soluble Fn14 Is Detected and Elevated in Mouse and Human Kidney DiseaseM Nusrat Sharif, Gabriela Campanholle, Eva E Nagiec, et al.
Plos One|July 27, 2017
High resolution molecular and histological analysis of renal disease progression in ZSF1 fa/faCP rats, a model of type 2 diabetic nephropathyKen Dower, Shanrong Zhao, Franklin J Schlerman, et al.
Journal of Crohn'S & Colitis|March 23, 2019
Molecular Profiling of Ulcerative Colitis Subjects from the TURANDOT Trial Reveals Novel Pharmacodynamic/Efficacy BiomarkersHuanyu Zhou, Li Xi, Daniel Ziemek, et al.
Scientific Reports|October 7, 2023
A protein kinase C α and β inhibitor blunts hyperphagia to halt renal function decline and reduces adiposity in a rat model of obesity-driven type 2 diabetesJu Wang, Agustin Casimiro-Garcia, Bryce G Johnson, et al.
Pageof 3